3139-06-8 Usage
Uses
Used in Pharmaceutical Industry:
1-Methoxy-2,5-diMethyl-4-nitrobenzene is used as a key intermediate in the synthesis of pharmaceuticals, contributing to the development of new drugs and medicinal compounds.
Used in Dye Industry:
In the dye industry, 1-Methoxy-2,5-diMethyl-4-nitrobenzene is utilized for the production of dyes, playing a significant role in the creation of colorants for various applications.
Used in Fragrance Industry:
1-Methoxy-2,5-diMethyl-4-nitrobenzene, is also employed as a component in the fragrance industry, where it contributes to the formulation of scented products, enhancing their aromatic profiles.
Used in Organic Synthesis:
1-Methoxy-2,5-diMethyl-4-nitrobenzene is used as an intermediate in organic synthesis, facilitating the production of a range of organic compounds for diverse applications across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 3139-06-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,1,3 and 9 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 3139-06:
(6*3)+(5*1)+(4*3)+(3*9)+(2*0)+(1*6)=68
68 % 10 = 8
So 3139-06-8 is a valid CAS Registry Number.
InChI:InChI=1/C9H11NO3/c1-6-5-9(13-3)7(2)4-8(6)10(11)12/h4-5H,1-3H3
3139-06-8Relevant academic research and scientific papers
QUINUCLIDINES FOR MODULATING ALPHA 7 ACTIVITY
-
Paragraph 0379; 0380, (2016/02/29)
Provided are substituted quinuclidine compounds, pharmaceutical compositions comprising such compounds, and methods of modulating α7 nicotinic acetylcholine receptors and treating neurological disorders using such compounds.
PROLYL HYDROXYLASE INHIBITORS
-
Page/Page column 19, (2010/07/10)
The invention described herein relates to certain 2,4-dioxo-l,2,3,4-tetrahydro-7- quinazolinecarboxamide derivatives of formula (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.
